"A comprehensive analysis of adverse events during clinical trials and over the course of mass vaccinations with the Sputnik V vaccine show...

Russia already has three coronavirus vaccines for humans, the most well known of which is Sputnik V. Moscow has also given emergency approv...

Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a simi...

Russia launched a voluntary vaccination programme with the Russia-made Sputnik V vaccine earlier in December, starting with the most vulner...

Russian President Vladimir Putin told the UN that Russia and the US should enter talks to extend the Strategic Arms Reduction Treaty, which...

Scientists around the world say any widely-used vaccine should first be tested in advanced trials involving tens of thousands of people to ...

Last week, Russia became the first country in the world to license a coronavirus vaccine when President Vladimir Putin announced its approv...

Lauding Russia for the vaccine, Raut, in his weekly column 'Rokhtokh' in the Shiv Sena mouthpiece 'Saamana', said this was a sign of being ...

The RDIF has funded research and production of Sputnik V, the world’s first approved coronavirus vaccine, developed by the Moscow-based Gam...

The world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairp...

Speaking at a government meeting on Tuesday, Vladimir Putin said that the vaccine has proven efficient during tests, offering a lasting imm...

Kirill Dmitriev, head of the RDIF sovereign wealth fund, said Russia had already received requests from more than 20 countries for 1 billio...

Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease b...

The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stag...

A source told Reuters this week that Russia's first potential COVID-19 vaccine, developed by a state research facility, would secure local ...

"RDIF is cooperating with Indian partners to share the most advanced practices to combat coronavirus, we have been in touch through the who...

Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University, told that the human t...